Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
misconduct
Research
NIH leader's research misconduct calls drugs into question
One of the drugs facing new questions is prasinezumab, an antibody for Parkinson’s disease being developed by Prothena Biosciences and Roche.
Darren Incorvaia
Sep 26, 2024 9:12am
DOJ probe report 'old news in new fish wrapper': Cassava CEO
Jul 27, 2022 3:01pm
Abeona ejects CEO Carsten Thiel for ‘personal misconduct’
Nov 27, 2018 8:29am